But accessibility also means the market is flooded with research-grade products that vary wildly in quality, which is exactly where problems start
But until now, there hasnt been any data from large epidemiologic studies. While GLP-1 medicationssuch as Ozempic, Wegovy, Rybelsus, and Mounjarowere developed to treat diabetes, the demand for the drugs as a weight management tool has surged since 2019, Healthcare Brew previously reported
Interplay between dysbiosis of gut microbiome, lipid metabolism, and tumorigenesis: can gut dysbiosis stand as a prognostic marker in cancer
For patients with obvious stomach issues or indications of slow metabolism, or those on higher doses, many surgeons request that they discontinue the medication early